Creatine therapy in myophosphorylase deficiency (McArdle disease): A placebo-controlled crossover trial

Archives of Neurology

Volumn 57, Issue 7, 2000, Pages 956-963

  Vorgerd, Matthias ^a,e   Grehl, T ^a   Jager M ^b   Muller K ^c   Freitag, G ^a   Patzold, T ^a   Bruns, N ^a   Fabian, K ^d   Tegenthoff, M ^a   Mortier, W ^a   Luttmann, A ^b   Zange, J ^c   Malin, J P ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^c GERMAN AEROSPACE CENTER DLR   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG TOLERABILITY; EXERCISE TOLERANCE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; MALE; MUSCLE CONTRACTION; MUSCLE FUNCTION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0033924202     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.7.956     Document Type: Article

References (40)

1. DiMauro S, Tsujino S. Nonlysosomal glycogenoses. In: Engel AG. Franzini-Armstrong C, eds. Myology. 2nd ed. New York, NY: McGraw-Hill Co; 1994:1554-1576.
2. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem J. 1992;281:21-40.
3. Connett R. Analysis of metabolic control: new insights using a scaled creatine model. Am J Physiol. 1988;254:R949-R959.
4. Kemp GK. Interactions of mitochondrial ATP synthesis phosphorus metabolite concentrations and the creatine kinase equilibrium in skeletal muscle. J Theor Biol. 1994;170:239-246.
5. Blei ML, Conley KE, Kushmerick MJ. Separate measures of ATP utilization and recovery in human skeletal muscle. J Physiol. 1993;465:203-222.
6. Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercising muscle of normal subjects by creatine supplementation. Clin Sci. 1992;83:367-374
7. Birch R, Noble D, Greenhaff PL. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol. 1994;69:268-270.
8. Balson PD, Söderlund K, Sjödin B, Ekblom B. Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. Acta Physiol Scand. 1995;154:303-310.
9. Cooke WH, Grandjean PW, Barnes WS. Effect of oral creatine supplementation on power output and fatigue during bicycle ergometry. J Appl Physiol. 1995;78:670-673
10. Earnest CP, Snell PG, Rodriguez R, Almada AL, Mitchell TL. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand. 1995;153:207-209.
11. Casey A, Constantin-Theodosiu D, Howell S, Hultman E, Greenhaff PL. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol. 1996;271:E31-E37.
12. Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol. 1997;83:2055-2063.
13. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997; 20:1502-1509.
14. Vorgerd M, Kubisch C, Burwinkel B, et al. Mutation analysis in myophosphorylase deficiency (McArdle's disease). Ann Neurol. 1998;43:326-331.
15. Medical Research Council Aids to the Examination of the Peripheral Nervous System, London. England: Her Majesty's Stationery Office: 1978.
16. Krupp LB, LaRocca NG, Muir-Nash J Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-1123.
17. Oversteegen HJ, de Boer J, Bakker AJ, van Leewen C. A simple enzymatic determination of creatine in serum with a commercial creatine kit. Clin Chem. 1987; 33:720-772.
18. 1P magnetic resonance spectroscopy. Neuromuscul Disord. 1998;8:480-488.
19. 11P NMR. Magn Reson Med. 1984;1:307-315.
20. Kushmerick MJ, Meyer RA, Brown TR. Regulation of oxygen consumption in fast- and slow-twitch muscle. Am J Physiol. 1992;263:C598-C606.
21. 11P nuclear magnetic resonance study. Mol Biol Med. 1983;1:77-94.
22. Luttmann A. Jäger M. Sökeland J, Laurig W. Electromyographical study on surgeons in urology, part II: determination of muscular fatigue Ergonomics. 1996; 39:298-313.
23. Stulen FB, De Luca CJ. Frequency parameters of the myoelectric signal as a measure of muscle conduction velocity. IEEE Trans Biomed Eng. 1981;28:515-523.
24. Jones B, Kenward MG. Design and Analysis of Cross-over Trials. London, England: Chapman & Hall: 1989.
25. Sahlin K, Areskog NH, Haller RG, Henriksson KG, Jorfeldt L, Lewis SF. Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease. J Appl Physiol. 1990;69:1231-1235.
26. DeStefano N, Argov Z, Matthews PM. Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease. Muscle Nerve. 1996;19:764-769.
27. Rowland LP, Araki S, Carmel P. Contracture in McArdle's disease: stability of adenosine triphosphate during contracture in phosphorylase-deficient human muscle. Arch Neurol. 1965;13:541-544.
28. Edwards RH, Wiles CM. Energy exchange in human skeletal muscle during isometric contraction. Circ Res. 1981;48(pt 2):I11-I17.
29. 11P nuclear magnetic resonance. N Engl J Med. 1981;304:1338-1342.
30. 11P-NMR: effect of glucose intusion. J Appl Physiol. 1985;59:1991-1994.
31. 11PMRS. Neurology. 1992;42(suppl 3): 387.
32. Ingwell JS, Weiner CD, Morales MF, Davis E, Stockdale FE. Specificity of creatine in the control of muscle protein synthesis. J Cell Physiol. 1974;63:145-151.
33. Sjogaard G. Exercise-induced muscle fatigue: the significance of potassium. Acta Physiol Scand Suppl. 1990;593:1-63.
34. Luttmann A. Physiological basis and concepts of electromyography. In: Kumar S. Mital A. eds. Electromyography in Ergonomics. London. England Taylor & Francis; 1996:51-95.
35. .-ATPase in McArdle disease. Neurology. 1998;50:37-40
36. .and ventilation during exercise in normal subjects and subjects with McArdle's syndrome. J Physiol. 1990;429:339-348.
37. Ruff LR. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fibre types. Acta Physiol Scand. 1996;156:159-168
38. Ruff LR. Why do patients with McArdle's disease have decreased exercise capacity? Neurology. 1998;50:6-7.
39. Dyken ML, Smith DM, Peake RL. An electromyographic diagnostic screening test in McArdle's disease and a case report. Neurology. 1967;17:45-50.
40. Vergara J, Bezanilla F, Salzberg BN. Nile blue fluorescence signals from cut single muscle fibers under voltage or current conditions J Gen Physiol 1978;72:775-800.